[go: up one dir, main page]

MA47687B1 - CLADE F ADENO-ASSOCIATED VIRUS VECTORS, AND THEIR USES - Google Patents

CLADE F ADENO-ASSOCIATED VIRUS VECTORS, AND THEIR USES

Info

Publication number
MA47687B1
MA47687B1 MA47687A MA47687A MA47687B1 MA 47687 B1 MA47687 B1 MA 47687B1 MA 47687 A MA47687 A MA 47687A MA 47687 A MA47687 A MA 47687A MA 47687 B1 MA47687 B1 MA 47687B1
Authority
MA
Morocco
Prior art keywords
raav
relates
associated virus
aavhu68
adeno
Prior art date
Application number
MA47687A
Other languages
French (fr)
Other versions
MA47687A (en
Inventor
James Wilson
Qiang Wang
April Giles
Kevin Turner
Original Assignee
Univ Pennsylvania
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pennsylvania filed Critical Univ Pennsylvania
Priority claimed from PCT/US2018/019992 external-priority patent/WO2018160582A1/en
Publication of MA47687A publication Critical patent/MA47687A/en
Publication of MA47687B1 publication Critical patent/MA47687B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A61K35/761—Adenovirus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14121—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14111—Dependovirus, e.g. adenoassociated viruses
    • C12N2750/14141—Use of virus, viral particle or viral elements as a vector
    • C12N2750/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

L'invention concerne un vecteur de virus adéno-associé recombinant (raav) comprenant une capside aavhu68 produite dans un système de production comprenant une séquence nucléotidique seq id no: 1, ou une séquence au moins identique à 75 % à celle-ci qui code pour la seq id no: 2. La capside aavhu68 comprend des sous-populations de résidus asparagine hautement désamidés dans des paires asparagine-glycine dans la séquence d'acides aminés seq id no: 2. L'invention concerne également des compositions comprenant le raav et des utilisations de celles-ci. De plus, l'invention concerne un raav ayant une capside aav modifiée comprenant au moins une sous-population de protéines vpl ou vp2 ayant une val à la position de l'acide aminé 157 par rapport à la numérotation de l'aavhu68 vpl.The invention relates to a recombinant adeno-associated virus (raav) vector comprising an aavhu68 capsid produced in a production system comprising a nucleotide sequence seq id no: 1, or a sequence at least 75% identical thereto which encodes for seq id no: 2. The aavhu68 capsid includes subpopulations of highly deamidated asparagine residues in asparagine-glycine pairs in the amino acid sequence seq id no: 2. The invention also relates to compositions comprising raav and uses thereof. Additionally, the invention relates to a raav having a modified aav capsid comprising at least one subpopulation of vpl or vp2 proteins having a val at amino acid position 157 relative to the numbering of aavhu68 vpl.

MA47687A 2017-02-28 2018-02-27 CLADE F ADENO-ASSOCIATED VIRUS VECTORS, AND THEIR USES MA47687B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762464748P 2017-02-28 2017-02-28
PCT/US2018/019992 WO2018160582A1 (en) 2017-02-28 2018-02-27 Adeno-associated virus (aav) clade f vector and uses therefor

Publications (2)

Publication Number Publication Date
MA47687A MA47687A (en) 2021-03-31
MA47687B1 true MA47687B1 (en) 2024-03-29

Family

ID=91034127

Family Applications (1)

Application Number Title Priority Date Filing Date
MA47687A MA47687B1 (en) 2017-02-28 2018-02-27 CLADE F ADENO-ASSOCIATED VIRUS VECTORS, AND THEIR USES

Country Status (1)

Country Link
MA (1) MA47687B1 (en)

Also Published As

Publication number Publication date
MA47687A (en) 2021-03-31

Similar Documents

Publication Publication Date Title
MX2024012403A (en) Adeno-associated virus (aav) clade f vector and uses therefor
FI3684786T3 (en) MUTATED GLYCOPROTEIN OF VESICULAR STOMATITI VIRUS
MA44683B1 (en) ADENO-ASSOCIATED VIRUS VECTOR DELIVERY FOR TREATING MUSCULAR DYSTROPHY
UA124343C2 (en) CAPSIDES OF ADENOSOCIATED VIRUS AND METHOD OF ITS USE
MX2020003176A (en) VARIANTS OF CAPSIDES OF ADENO-ASSOCIATED VIRUSES AND METHODS OF USE OF THESE.
EP4467650A3 (en) Scaffold proteins
ZA202105975B (en) Variant aav capsids for intravitreal delivery
EA202091712A1 (en) MODIFIED rAAV CAPSID PROTEIN FOR GENE THERAPY
WO2022076750A3 (en) Recombinant adeno-associated viruses for cns or muscle delivery
WO2022232327A3 (en) Aav capsids and uses thereof
MA56142B1 (en) SEPARATE MODIFIED CAPSID PROTEIN VP1 FROM AAV5
NO20081654L (en) Stabilized GLP-1 analogs
PH12022550109A1 (en) Modified aav capsid proteins for treatment of arthritic disease
WO2021239838A3 (en) Severe acute respiratory syndrome coronavirus 2 (sars-cov-2) polypeptides and uses thereof for vaccine purposes
MA56910A1 (en) cca gene for virus resistance
MA47687B1 (en) CLADE F ADENO-ASSOCIATED VIRUS VECTORS, AND THEIR USES
ZA202409276B (en) Aav vector encoding diamine oxidase and uses thereof
DE602005018615D1 (en) POLYPEPTIDES AND THEIR USE AS VACCINES AND IN IMMUNE THERAPY
EA201992023A1 (en) VECTOR BASED ON Adeno-ASSOCIATED VIRUS (AAV) FOLDERS AND ITS APPLICATIONS
MX2023003807A (en) Recombinant adeno-associated viruses for cns or muscle delivery.
BR112022003206A2 (en) METHODS TO TREAT NEOVASCULAR EYE DISEASES USING AAV2 VARIANTS ENCODING AFLIBERCEPTE
MA64618A1 (en) SEPARATE MODIFIED PROTEIN VP1 FROM AAV9 CAPSID
MA64619A1 (en) SEPARATE MODIFIED PROTEIN VP1 FROM AAV5 CAPSID
WO2023060272A3 (en) Recombinant adeno-associated viruses for cns tropic delivery
WO2023250447A3 (en) Methods of selection and use of engineered cyclic peptides for enhancing viral production